Transplant Genomics
CMS Clarifies Billing Article Revisions for Organ Transplant Rejection Testing
A statement from CMS clarifies that physician-ordered transplant rejection tests remain available when medically necessary.
Illumina, Devyser Diagnostics Ink IVD Development Agreement
The agreement will enable Sweden's Devyser to perform regulatory registrations of its NGS-based IVD tests on Illumina's MiSeqDx sequencer in the US and Europe.
In Brief This Week: CareDx; Proteomics International; Pangea Laboratory
News items for the week of Dec. 18, 2023
Immucor, Pirche Partner to Embed Epitope Matching Prediction Pipeline into Transplant Dx Software
An unspecified investment will give Immucor exclusive access to PIRCHE scores and embedded visualizations for HLA antibody analysis.
Transplant Genomics, Viracor Eurofins Partner for Remote Sample Collection
The deal includes key testing services like Transplant's TruGraf blood test and Viracor's TRAC test, along with Viracor Eurofins' new SARS-CoV-2 test.